Evotec receives milestone as part of its multi-target alliance with Bayer HealthCare
Evotec announced that its multi-target collaboration with Bayer HealthCare has reached an important milestone for the transition of a molecule into pre-clinical development for treatment of endometriosis. This milestone was achieved under the agreement between Evotec and Bayer signed in Oct. 2012. September 30, 2014